Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Eurofins Scientific SE    ERF   FR0014000MR3

EUROFINS SCIENTIFIC SE

(ERF)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
01/20/2021 01/21/2021 01/22/2021 01/25/2021 01/26/2021 Date
77.97(c) 78.28(c) 78(c) 78.18(c) 79.88(c) Last
201 311 315 013 242 893 346 794 338 078 Volume
+0.72% +0.40% -0.36% +0.23% +2.17% Change
More quotes
Financials
Sales 2020 5 399 M 6 568 M 6 568 M
Net income 2020 415 M 505 M 505 M
Net Debt 2020 2 757 M 3 354 M 3 354 M
P/E ratio 2020 37,2x
Yield 2020 0,65%
Sales 2021 5 663 M 6 889 M 6 889 M
Net income 2021 458 M 558 M 558 M
Net Debt 2021 2 510 M 3 053 M 3 053 M
P/E ratio 2021 33,8x
Yield 2021 0,62%
Capitalization 15 241 M 18 536 M 18 540 M
EV / Sales 2020 3,33x
EV / Sales 2021 3,13x
Nbr of Employees 48 000
Free-Float 66,7%
More Financials
Company
Eurofins Scientific SE is a Luxembourg-based company engaged in the business support services industry. The Company joins a part of international group of laboratories providing a range of analytical testing services to the pharmaceutical, food, environmental and consumer products industries and to governments. It operates through a number of subsidiaries, such as VRL Laboratories in the United States, Institut... 
More about the company
Notations Surperformance© of Eurofins Scientific SE
Trading Rating : Investor Rating :
More Ratings
All news about EUROFINS SCIENTIFIC SE
01/25EUROFINS SCIENTIFIC : FY20 Revenue Beats Estimates to Reach $6.6 Billion
MT
01/25EUROFINS SCIENTIFIC : Achieved Revenues in Excess of EUR 5.4bn in 2020, After Co..
BU
01/18EUROFINS SCIENTIFIC : Bioanalytical Services launches Surrogate Virus Neutralizi..
PU
01/15Eurofins Launches New Test, Increased Capacity to Detect SARS-CoV-2 Variants
MT
01/15EUROFINS : the global leader in analytical testing, expands worldwide face mask ..
BU
01/15EUROFINS SCIENTIFIC : Launches New Tests and Massive Capacity for Detecting and ..
BU
01/11EUROFINS SCIENTIFIC : Anti-COVID-19 System Gets Emergency Response Validation PT..
MT
01/11EUROFINS SCIENTIFIC : GeneScan Technologies Announces AOAC PTM Accreditation for..
BU
2020EUROFINS SCIENTIFIC : Launches Full-Length COVID-19Viral Genome Sequencing Servi..
MT
2020EUROFINS SCIENTIFIC : Genomics Launches Cost-Effective SARS-CoV-2 full-length Vi..
BU
2020EUROFINS CEREP : Launches PCR COVID-19 Self-Test In Germany, Spain
MT
2020EUROFINS SCIENTIFIC : launches COVID-19 PCR tests with at-home self-sampling opt..
PU
2020EUROFINS SCIENTIFIC : Lifts FY20 Revenue, Profit Outlook On Strong Trading, Orga..
MT
2020EUROFINS SCIENTIFIC : Raises Its 2020 Objectives After Strong Momentum in Its Co..
BU
2020EUROFINS TECHNOLOGIES : Launches New and Improved Lateral Flow Device Product Li..
BU
More news
News in other languages on EUROFINS SCIENTIFIC SE
11:43aEUROFINS SCIENTIFIC : dans le vert, soutenu par une analyse
09:22aEUROFINS : Credit Suisse remonte son objectif de cours
06:07aEUROFINS : détection des variants possible avec le kit
04:56aEUROFINS SCIENTIFIC : Credit Suisse relève son objectif de cours
01/25EUROFINS SCIENTIFIC : dégradé par un analyste malgré une activité 2020 supérieur..
More news
Analyst Recommendations on EUROFINS SCIENTIFIC SE
More recommendations
Stock Trading Strategies
EUROFINS SCIENTIFIC - 01/19
Good timing to anticipate a continuation of the trend
BUY
More Stock Trading Analysis
Chart EUROFINS SCIENTIFIC SE
Duration : Period :
Eurofins Scientific SE Technical Analysis Chart | ERF | FR0014000MR3 | MarketScreener
Technical analysis trends EUROFINS SCIENTIFIC SE
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 74,39 €
Last Close Price 79,88 €
Spread / Highest target 6,53%
Spread / Average Target -6,87%
Spread / Lowest Target -52,2%
EPS Revisions
Managers and Directors
NameTitle
Gilles J. Martin Chairman & Chief Executive Officer
Laurent Lebras Director-Group Finance & Administration
Andreas König Chief Information Officer
Yves-Loïc Martin Non-Executive Director
Valérie Hanote Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
EUROFINS SCIENTIFIC SE16.39%18 089
SQUARE, INC.-3.89%97 691
FISERV, INC.-6.72%71 542
GLOBAL PAYMENTS INC.-14.08%55 401
OFFCN EDUCATION TECHNOLOGY CO., LTD.8.77%36 367
CINTAS CORPORATION-8.57%34 463